Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-25-000067

Chief Medical Officer sold 11,366 shares at $14.60 ($165,931)

  • Chief Medical Officer acquired 6,348 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rodman David Malcom Chief Medical Officer 2025-06-12 Option exercise 10b5-1 +6,348 $1.08 $6,856 113,017 D
Rodman David Malcom Chief Medical Officer 2025-06-13 Sale 10b5-1 −11,366 $14.60 $165,931 101,651 D
Derivatives
Rodman David Malcom Chief Medical Officer 2025-06-12 Option exercise · Stock Option 10b5-1 −6,348 95,229 D
Open-market sales · 11,366 sh · avg $14.60 · $165,931
Loading xslF345X05/wk-form4_1750104191.xml…